Literature DB >> 21699063

SiRNA delivery: challenges and role of carrier systems.

R Shegokar1, L Al Shaal, P R Mishra.   

Abstract

Gene silencing by RNA interference is a rapidly growing therapeutic area for managing diseases. Despite research advances in this direction, the poor cellular uptake of synthetic small interfering RNAs is a major impediment to their clinical applications. Polymer and lipid-based systems are attractive carrier systems for delivery of siRNA and provide options for desirable engineering of carrier particles. In this review, there is a detailed discussion of RNAi delivery systems and recent advances in the field.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21699063

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  13 in total

1.  Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo.

Authors:  So C Wong; Jason J Klein; Holly L Hamilton; Qili Chu; Christina L Frey; Vladimir S Trubetskoy; Julia Hegge; Darren Wakefield; David B Rozema; David L Lewis
Journal:  Nucleic Acid Ther       Date:  2012-12       Impact factor: 5.486

2.  Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.

Authors:  Shan Lu; Viola B Morris; Vinod Labhasetwar
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

3.  Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.

Authors:  Maneesh Gujrati; Anthony Malamas; Tesia Shin; Erlei Jin; Yunlu Sun; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2014-07-14       Impact factor: 4.939

Review 4.  Image-guided nanosystems for targeted delivery in cancer therapy.

Authors:  A K Iyer; J He; M M Amiji
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration.

Authors:  Toshihiko Mikami; Satoshi Maruyama; Tatsuya Abé; Takanori Kobayashi; Manabu Yamazaki; Akinori Funayama; Susumu Shingaki; Tadaharu Kobayashi; Cheng Jun; Takashi Saku
Journal:  Virchows Arch       Date:  2015-03-04       Impact factor: 4.064

6.  Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.

Authors:  Aritra Sengupta; Roman Mezencev; John F McDonald; Mark R Prausnitz
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

7.  Microfabricated arrays for splitting and assay of clonal colonies.

Authors:  Philip C Gach; Wei Xu; Samantha J King; Christopher E Sims; James Bear; Nancy L Allbritton
Journal:  Anal Chem       Date:  2012-11-29       Impact factor: 6.986

8.  Silencing the gene encoding C/EBP homologous protein lessens acute brain injury following ischemia/reperfusion.

Authors:  Fengzhang Wang; Yuan Zhang; Chunke He; Tingting Wang; Qiyan Piao; Qun Liu
Journal:  Neural Regen Res       Date:  2012-11-05       Impact factor: 5.135

9.  Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model.

Authors:  Yan Chen; Lifang Yang; Suping Huang; Zhi Li; Lu Zhang; Jiang He; Zhijie Xu; Liyu Liu; Ya Cao; Lunquan Sun
Journal:  Int J Nanomedicine       Date:  2013-08-14

10.  An amine oxidase gene from mud crab, Scylla paramamosain, regulates the neurotransmitters serotonin and dopamine in vitro.

Authors:  Junguo Liu; Ming Zhao; Wei Song; Lingbo Ma; Xiu Li; Fengying Zhang; Le Diao; Yan Pi; Keji Jiang
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.